Rechallenge with EGFR-TKI after failure of immunotherapy is considered an effective treatment for advanced lung adenocarcinoma patients with EGFR exon 19 deletion: a case report

In advanced lung adenocarcinoma patients with epidermal growth factor receptor (EGFR) mutation, epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have an excellent and long-lasting therapeutic response; however, virtually all patients eventually develop drug resistance and expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shubin, Yu, Qitao, Jiang, Wei, Lu, Yukun, Zhao, Yun, Wang, Huilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339383/
https://www.ncbi.nlm.nih.gov/pubmed/37457583
http://dx.doi.org/10.3389/fmed.2023.1168220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339383/
https://www.ncbi.nlm.nih.gov/pubmed/37457583
http://dx.doi.org/10.3389/fmed.2023.1168220

Ejemplares similares